Correlation Between AptaBio Therapeutics and Global Standard

Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Global Standard at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Global Standard into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AptaBio Therapeutics and Global Standard Technology, you can compare the effects of market volatilities on AptaBio Therapeutics and Global Standard and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Global Standard. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Global Standard.

Diversification Opportunities for AptaBio Therapeutics and Global Standard

0.37

Correlation Coefficient

AptaBio Therapeutics  Global Standard

Weak diversification

The 3 months correlation between AptaBio and Global is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Global Standard Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Global Standard Tech and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Global Standard. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Global Standard Tech has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Global Standard go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Global Standard

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Global Standard. But the stock apears to be less risky and, when comparing its historical volatility, AptaBio Therapeutics is 1.36 times less risky than Global Standard. The stock trades about -0.08 of its potential returns per unit of risk. The Global Standard Technology is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  1,546,255  in Global Standard Technology on October 5, 2024 and sell it today you would earn a total of  159,745  from holding Global Standard Technology or generate 10.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.0%
Values	Daily Returns

AptaBio Therapeutics  vs.  Global Standard Technology

AptaBio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Global Standard Tech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Global Standard Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Global Standard is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with AptaBio Therapeutics and Global Standard

The main advantage of trading using opposite AptaBio Therapeutics and Global Standard positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Global Standard can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Global Standard will offset losses from the drop in Global Standard's long position.

The idea behind AptaBio Therapeutics and Global Standard Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.